
Explanation:
The MEASURE function aligns with the role described in the scenario. It is specifically designed to analyze, assess, benchmark, and monitor the risks and impacts associated with AI systems, employing a variety of tools and methodologies. In the context of healthcare AI solutions, this function is crucial for ensuring the safety, efficacy, and reliability of AI applications, through rigorous testing and continuous monitoring.
A, B, and D are incorrect as they describe other functions of the AI RMF that do not align with the role described in the scenario. The GOVERN function (A) focuses on establishing a risk management culture and aligning AI risk management with organizational principles. The MAP function (B) is concerned with framing risks by understanding the AI system's lifecycle and the interdependencies among different activities and actors. The MANAGE function (D) involves allocating resources for risk management and implementing response plans for AI-related incidents. While these functions are important in the AI RMF, they do not match the specific focus on analysis, assessment, benchmarking, and monitoring of AI risks described for the MEASURE function.
Things to Remember
Ultimate access to all questions.
Q.5607 In your role as the AI Compliance Officer at "Digital Health Innovations," a company specializing in AI-driven healthcare solutions, you are tasked with implementing a specific function of the AI Risk Management Framework (AI RMF). This function is integral for systematically analyzing, assessing, and monitoring the various risks and impacts associated with the company's AI systems. It involves using a blend of quantitative, qualitative, or mixed-method tools, techniques, and methodologies. The function is vital for ensuring that the AI systems in healthcare are tested rigorously before deployment and monitored continuously during operation. Which of the following functions is described in the above scenario?
A
GOVERN function
B
MAP function
C
MEASURE function
D
MANAGE function
No comments yet.